These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 711852)

  • 1. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.
    Jaffe CJ; Vierling JM; Jones EA; Lawley TJ; Frank MM
    J Clin Invest; 1978 Nov; 62(5):1069-77. PubMed ID: 711852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of C3b-binding in chronic liver diseases.
    Hautanen A; Salaspuro MP
    Scand J Gastroenterol; 1981; 16(4):505-12. PubMed ID: 7323688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective reticuloendothelial system C3b mediated clearance in rheumatoid arthritis and vasculitis.
    Cunningham TJ; Nicholls KM; Chen SL; Mathews JD; Muirden KD
    J Rheumatol; 1985 Aug; 12(4):675-9. PubMed ID: 4057188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
    Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
    J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective splenic reticuloendothelial function in idiopathic membranous nephropathy.
    McGinley E; Martin W; Henderson N; Boulton-Jones JM
    Clin Exp Immunol; 1984 May; 56(2):295-301. PubMed ID: 6587955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH conference. Primary biliary cirrhosis and the complement system.
    Ann Intern Med; 1979 Jan; 90(1):72-84. PubMed ID: 420467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mononuclear cell complement receptor blockade in primary biliary cirrhosis.
    Al-Aghbar MN; Neuberger J; Williams R; Eddleston AL
    Gut; 1985 Jan; 26(1):20-5. PubMed ID: 3155513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear autoantibodies in chronic liver diseases.
    Konikoff F; Isenberg DA; Barrison I; Theodor E; Shoenfeld Y
    Hepatogastroenterology; 1989 Oct; 36(5):341-5. PubMed ID: 2620901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective Fc receptor-mediated clearance in patients with primary biliary cirrhosis.
    Ekdahl KN; Lööf L; Nyberg A; Nilsson UR; Nilsson B
    Gastroenterology; 1991 Oct; 101(4):1076-82. PubMed ID: 1889700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective elimination of C3b/iC3b-coated autologous erythrocytes in patients with primary biliary cirrhosis, alcoholic cirrhosis, and ulcerative colitis.
    Nilsson Ekdahl K; Lööf L; Ahrenstedt O; Nilsson UR; Nilsson B
    J Lab Clin Med; 1997 Sep; 130(3):285-92. PubMed ID: 9341988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis.
    Haruta I; Hashimoto E; Kato Y; Kikuchi K; Kato H; Yagi J; Uchiyama T; Kobayash M; Shiratori K
    Autoimmunity; 2006 Mar; 39(2):129-35. PubMed ID: 16698669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity?
    van der Woude FJ; van der Giessen M; Kallenberg CG; Ouwehand W; Beekhuis H; Beelen JM; van Son WJ; Hoedemaeker PJ; van der Hem GK; The TH
    Clin Exp Immunol; 1984 Mar; 55(3):473-80. PubMed ID: 6584255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis.
    Bittencourt PL; Farias AQ; Abrantes-Lemos CP; Goncalves LL; Goncalves PL; Magalhães EP; Carrilho FJ; Laudanna AA; Cançado EL
    J Gastroenterol Hepatol; 2004 Aug; 19(8):873-8. PubMed ID: 15242489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
    Sasaki M; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases.
    De Fernandez MA; Clark A; Triger DR
    Clin Exp Immunol; 1987 Mar; 67(3):655-61. PubMed ID: 3608234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes.
    Björkland A; Lööf L; Mendel-Hartvig I; Tötterman TH
    J Immunol; 1994 Sep; 153(6):2750-7. PubMed ID: 8077679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation in chronic liver disease.
    Munoz LE; De Villiers D; Markham D; Whaley K; Thomas HC
    Clin Exp Immunol; 1982 Mar; 47(3):548-54. PubMed ID: 7083631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.